A detailed history of Legal & General Group PLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 96,370 shares of BIO stock, worth $31.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
96,370
Previous 96,370 -0.0%
Holding current value
$31.9 Million
Previous $32.2 Million -0.0%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$263.97 - $344.64 $10.6 Million - $13.8 Million
-40,074 Reduced 29.37%
96,370 $32.2 Million
Q2 2024

Aug 14, 2024

SELL
$268.26 - $339.48 $2.87 Million - $3.64 Million
-10,716 Reduced 7.28%
136,444 $37.3 Million
Q1 2024

Jul 01, 2024

BUY
$304.11 - $351.99 $1.07 Million - $1.24 Million
3,510 Added 2.44%
147,160 $50.9 Million
Q1 2024

May 14, 2024

SELL
$304.11 - $351.99 $2.42 Million - $2.81 Million
-7,973 Reduced 5.26%
143,650 $49.7 Million
Q4 2023

Feb 15, 2024

BUY
$269.37 - $365.04 $5.72 Million - $7.75 Million
21,239 Added 16.29%
151,623 $49 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $2.49 Million - $3.01 Million
-7,113 Reduced 5.17%
130,384 $46.7 Million
Q2 2023

Aug 14, 2023

BUY
$359.49 - $486.4 $1.2 Million - $1.63 Million
3,348 Added 2.5%
137,497 $52.1 Million
Q1 2023

May 15, 2023

SELL
$418.69 - $503.0 $566,906 - $681,062
-1,354 Reduced 1.0%
134,149 $64.3 Million
Q4 2022

Feb 14, 2023

SELL
$351.71 - $456.01 $3.16 Million - $4.1 Million
-8,985 Reduced 6.22%
135,503 $57 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $1.52 Million - $2.08 Million
-3,686 Reduced 2.49%
144,488 $60.3 Million
Q2 2022

Aug 22, 2022

SELL
$463.67 - $597.16 $5.33 Million - $6.86 Million
-11,488 Reduced 7.2%
148,174 $73.3 Million
Q1 2022

May 16, 2022

BUY
$524.57 - $735.42 $1.7 Million - $2.38 Million
3,243 Added 2.07%
159,662 $89.9 Million
Q4 2021

Feb 14, 2022

SELL
$708.84 - $794.68 $4.97 Million - $5.57 Million
-7,015 Reduced 4.29%
156,419 $118 Million
Q3 2021

Nov 15, 2021

SELL
$657.71 - $825.77 $3.65 Million - $4.59 Million
-5,556 Reduced 3.29%
163,434 $122 Million
Q2 2021

Aug 12, 2021

BUY
$576.64 - $649.04 $4.47 Million - $5.03 Million
7,752 Added 4.81%
168,990 $109 Million
Q1 2021

May 17, 2021

BUY
$547.01 - $662.35 $2.4 Million - $2.9 Million
4,382 Added 2.79%
161,238 $92.1 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $635,796 - $801,095
1,245 Added 0.8%
156,856 $91.4 Million
Q3 2020

Nov 13, 2020

BUY
$454.43 - $535.6 $23.5 Million - $27.7 Million
51,627 Added 49.65%
155,611 $80.2 Million
Q2 2020

Aug 14, 2020

SELL
$334.87 - $493.06 $3 Million - $4.42 Million
-8,973 Reduced 7.94%
103,984 $46.9 Million
Q1 2020

May 14, 2020

BUY
$320.01 - $409.07 $1.2 Million - $1.54 Million
3,754 Added 3.44%
112,957 $39.6 Million
Q4 2019

Feb 13, 2020

BUY
$319.73 - $374.2 $16.4 Million - $19.2 Million
51,311 Added 88.63%
109,203 $40.4 Million
Q3 2019

Nov 13, 2019

BUY
$304.55 - $345.24 $3.09 Million - $3.5 Million
10,137 Added 21.23%
57,892 $19.3 Million
Q2 2019

Aug 14, 2019

BUY
$286.93 - $312.59 $5.06 Million - $5.51 Million
17,626 Added 58.5%
47,755 $14.9 Million
Q1 2019

May 15, 2019

BUY
$224.3 - $317.41 $196,711 - $278,368
877 Added 3.0%
30,129 $9.21 Million
Q4 2018

Feb 15, 2019

BUY
$220.1 - $309.0 $351,059 - $492,855
1,595 Added 5.77%
29,252 $6.79 Million
Q3 2018

Nov 20, 2018

BUY
$289.28 - $326.15 $54,384 - $61,316
188 Added 0.68%
27,657 $8.66 Million
Q2 2018

Aug 10, 2018

SELL
$244.1 - $303.88 $208,949 - $260,121
-856 Reduced 3.02%
27,469 $7.93 Million
Q1 2018

May 17, 2018

BUY
$233.97 - $274.11 $345,339 - $404,586
1,476 Added 5.5%
28,325 $7.08 Million
Q4 2017

Feb 13, 2018

BUY
$216.94 - $271.3 $5.82 Million - $7.28 Million
26,849
26,849 $6.41 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.15B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.